Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Long-Term Investments (2016 - 2025)

Biomerica's Long-Term Investments history spans 15 years, with the latest figure at $165000.0 for Q4 2025.

  • For Q4 2025, Long-Term Investments changed 0.0% year-over-year to $165000.0; the TTM value through Nov 2025 reached $165000.0, changed 0.0%, while the annual FY2025 figure was $165000.0, 0.0% changed from the prior year.
  • Long-Term Investments for Q4 2025 was $165000.0 at Biomerica, roughly flat from $165000.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $165324.0 in Q1 2021 and bottomed at $165000.0 in Q2 2022.
  • The 5-year median for Long-Term Investments is $165000.0 (2022), against an average of $165129.6.
  • The largest annual shift saw Long-Term Investments changed 0.0% in 2021 before it decreased 0.2% in 2022.
  • A 5-year view of Long-Term Investments shows it stood at $165324.0 in 2021, then changed by 0.0% to $165324.0 in 2022, then fell by 0.2% to $165000.0 in 2023, then changed by 0.0% to $165000.0 in 2024, then changed by 0.0% to $165000.0 in 2025.
  • Per Business Quant, the three most recent readings for BMRA's Long-Term Investments are $165000.0 (Q4 2025), $165000.0 (Q3 2025), and $165000.0 (Q2 2025).